Viemed Healthcare (VMD) Enterprise Value (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.07% |
| Dec 31, 2025 | -24.78% |
| Sep 30, 2025 | 49.04% |
| Jun 30, 2025 | -121.91% |
| Mar 31, 2025 | 47.75% |
| Dec 31, 2024 | -64.36% |
| Sep 30, 2024 | -35.91% |
| Jun 30, 2024 | 4.26% |
| Mar 31, 2024 | 43.07% |
| Dec 31, 2023 | -27.40% |
| Sep 30, 2023 | 1.43% |
| Jun 30, 2023 | 56.57% |
| Mar 31, 2023 | -39.20% |
| Dec 31, 2022 | 21.25% |
| Sep 30, 2022 | 2.03% |
| Jun 30, 2022 | 25.05% |
| Mar 31, 2022 | -2.96% |
| Dec 31, 2021 | -5.74% |
| Sep 30, 2021 | 13.75% |
| Jun 30, 2021 | -0.17% |
| Mar 31, 2021 | -0.37% |
| Dec 31, 2020 | 4.37% |
| Sep 30, 2020 | -9.05% |
| Jun 30, 2020 | -253.28% |
| Mar 31, 2020 | 37.03% |
| Dec 31, 2019 | -5.74% |
| Sep 30, 2019 | -64.22% |
| Jun 30, 2019 | -3.79% |
| Mar 31, 2019 | 28.84% |
| Dec 31, 2018 | -2.35% |
| Sep 30, 2018 | -18.98% |
| Jun 30, 2018 | -84.53% |